What's more, an oxaliplatin-resistant CRC cell line was established to further evaluate the role of LDB1 in chemotherapy resistance, and LDB1 was found upregulated in oxaliplatin-resistant CRC cells. The gene discussed is LDB1; the disease is colorectal carcinoma.